Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Declares Share Buyback Plan

Posted by George Bondi on Oct 6th, 2026

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) declared that its board has approved a stock repurchase program on Tuesday, October 6th, RTT News reports. The company plans to buyback $20.00 million in shares. This buyback authorization permits the company to purchase up to 20.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Greenland Mines Ltd. Common Stock Stock Down 13.1%

GRML stock traded down $0.96 during midday trading on Tuesday, hitting $6.38. The company’s stock had a trading volume of 4,799,396 shares, compared to its average volume of 24,034,420. The firm has a 50-day simple moving average of $7.93 and a 200-day simple moving average of $14.90. The firm has a market capitalization of $85.17 million, a P/E ratio of -0.55 and a beta of 6.26. Greenland Mines Ltd. Common Stock has a 52-week low of $2.82 and a 52-week high of $36.99.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) last posted its quarterly earnings data on Monday, August 17th. The company reported ($0.03) earnings per share for the quarter.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, August 29th. Weiss Ratings raised Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Check Out Our Latest Research Report on Greenland Mines Ltd. Common Stock

Insider Activity at Greenland Mines Ltd. Common Stock

In related news, CFO Jeff Leblanc purchased 14,000 shares of the business’s stock in a transaction on Tuesday, August 25th. The shares were bought at an average price of $9.72 per share, for a total transaction of $136,080.00. Following the acquisition, the chief financial officer directly owned 110,406 shares in the company, valued at $1,073,146.32. This trade represents a 14.52% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Riad Hussein El-Dada sold 3,500 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $9.35, for a total value of $32,725.00. The SEC filing for this sale provides additional information. 11.30% of the stock is currently owned by company insiders.

Greenland Mines Ltd. Common Stock Company Profile

Get Free Report)

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan’s Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.